Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00589368 · ClinicalTrials.gov registry record
Transfer of Grasp Control Across Hands After Stroke
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 58
- Enrollment target
NCT00589368: Completed study, sponsored by NYU Langone Health.
NCT00589368 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 58 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00589368 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
Study Summary
The purpose of this study is to examine if the strong hand can assist in the recovery of muscle function in the weak hand after a stroke.
Interventions
- BEHAVIORAL Transfer of grasp control across hands
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2006-05 |
| Est. Completion | 2012-05 |
What the finished NCT00589368 record still lists
NCT00589368 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 58 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Transfer of grasp control across hands is the first listed.
NCT00589368 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00589368 about?
NCT00589368 is a clinical study titled "Transfer of Grasp Control Across Hands After Stroke". The purpose of this study is to examine if the strong hand can assist in the recovery of muscle function in the weak hand after a stroke.
What is the current status of trial NCT00589368?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2006-05. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00589368?
The interventions under investigation include: Transfer of grasp control across hands (BEHAVIORAL).
Who is sponsoring clinical trial NCT00589368?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia